Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
97. Treatment of premenstrual syndrome with continuous low dosage sertralin<br />
Tammaro Emanuela*, Milano W., Milano L., Rundle-Smith S., Petrella C., Capasso A.*<br />
Mental Health Operations Unit District 44 ASL Napoli 1 and *Department of Pharmaceutical<br />
Sciences, University of Salerno, Italy<br />
98. Novel therapeutic opportunities in unipolar depression<br />
Corsi Mauro, W.P.<br />
Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithkline S.p.A., Verona, Italy<br />
99. Lifestyle interventions on bodyweight gain olanzapine-induced: result from a<br />
randomized-controlled trial<br />
Cammarano Michela*, Milano W., Comazzi M.°, Milano L., Petrella C., Capasso A.*<br />
Unità Operativa Salute Mentale Distretto 44 ASL Napoli1; * Department of Pharmaceutical<br />
Sciences, University of Salerno, Italy; ° Unità <strong>di</strong> Psichiatria Azienda Ospedaliera <strong>di</strong> Melegnano<br />
Milano<br />
124<br />
100. Tolerability of antipsychotics in children and adolescents: a prospective study<br />
Alacqua Marianna 1 , Trifirò G. 1,4 , Arcoraci V. 1 , Germanò E. 2 , Gagliano A. 2 , Siracusano M. 2 , Di<br />
Vita G. 3 , Gagliano C. 3 , Spina E. 1, 4<br />
1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Pharmacology Unit,<br />
University of Messina, Italy - 2 Division of Child Neurology and Psychiatry, University of<br />
Messina, Italy - 3 Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS),<br />
Troina, Italy; 4 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy<br />
101. Plasma concentrations of quetiapine during coadministration with antiepileptic<br />
drugs in psychiatric patients<br />
D’Arrigo Concetta 1 , Migliar<strong>di</strong> G. 1 , Santoro V. 2 , Muscatello M.R. 3 , Zoccali R. 3 , Spina E 1,2<br />
1 Section of Pharmacology, Department of Clinical and Experimental Me<strong>di</strong>cine and<br />
Pharmacology, 2 IRCCS Centro Neurolesi “Bonino-Pulejo” and 3 Department of Neurosciences,<br />
Psychiatric and Anesthesiological Sciences, University of Messina, Messina, Italy<br />
102. Potential application of testosterone metabolites in the treatment of<br />
adrenoleukodystrophy<br />
Carissimi Romina 1 , Blasevich M. 1 , Cappa M. 2 , Uziel G. 3, Petroni A. 1<br />
1 Depart. of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133 Milan, Italy;<br />
2 Depart. of Pe<strong>di</strong>atrics Me<strong>di</strong>cine, Children’s Hospital “Bambino Gesù”, IRCCS, Rome, Italy;<br />
3 Child Neurology Dep., Istituto Neurologico “C. Besta”, Milan, Italy<br />
103. Development of specific biomarkers for als clinical progression: validation and<br />
potential roles in pathogenesis<br />
Bonini Sara A. 1 , Zhao Z. 2 , Lange D. J 3 ., Ho L. 2 , Yemul S. 2 , Wang J. 2 , Salton S. 4 , Memo M. 1 ,<br />
Pasinetti G.M. 2<br />
1 Department of Biome<strong>di</strong>cal Sciences and Biotechnologies, University of Brescia, Brescia, Italy;<br />
2 Department of Psychiatry, 3 Department of Neurology, 4 Department of Neuroscience, Mount<br />
Sinai School of Me<strong>di</strong>cine, New York, New York, USA<br />
pag_sx.indd 1 30/05/2007 5.37.18